Corporation reported its fourth-quarter 2024 earnings, surpassing analysts' expectations with an earnings per share (EPS) of $0.76 against the forecast of $0.74. Revenue also exceeded projections, ...

Bruker Corporation (Nasdaq: BRKR) today announced financial results for its fourth quarter and for the full year ended December 31, 2024. Frank H. Laukien, Bruker's ...

The "Spatial Proteomics market - Global industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ResearchAndMarkets.com's offering. The Spatial Proteomics Market ...

Browse 400 market data Tables and 50 Figures spread through 250 Pages and in-depth TOC on "Mass Spectrometry Market by ...

Bruker Corporation (Nasdaq: BRKR) today announced it will report fourth quarter and fiscal year 2024 financial results before ...

The Mass Spectrometry market valued at US$ 5.82 Billion in 2023, is forecasted to grow at a robust CAGR of 7.2%, reaching US$ ...

In our Proteomics Playbook we outline the principles, methods and available technologies to help you overcome common hurdles faced by the proteomics field. This report will help you explore the basic ...

It offers new possibilities in subcellular proteomics. Bruker also introduced the neofleX MALDI-TOF/TOF multiomic Mass Spec Imaging Benchtop system, which is set to enable multiomic colocalization ...

Bruker ’s BRKR strong growth reflects its fundamental commitment to innovate high-value solutions and its ongoing portfolio transformation. Yet, the company’s operations face the wrath of excessive ...